Skip to content
zameds

Methylphenidate (Aterocon La)

Methylphenidate

Austell Pharmaceuticals (Pty) Ltd

S6

Registration

Applicant
Austell Pharmaceuticals (Pty) Ltd
Registrations
4
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Aterocon la 20 MG

EACH CAPSULE CONTAINS METHYLPHENIDATE HYDROCHLORIDE 20,0 mg

20 mg54043254/1.2/0432RegisteredS6None
Aterocon la 30 MG

EACH CAPSULE CONTAINS METHYLPHENIDATE HYDROCHLORIDE 30,0 mg

30 mg54043354/1.2/0433RegisteredS6None
Aterocon la 40 MG

EACH CAPSULE CONTAINS METHYLPHENIDATE HYDROCHLORIDE 40,0 mg

40 mg54043454/1.2/0434RegisteredS6None
Aterocon la 60 MG

EACH CAPSULE CONTAINS METHYLPHENIDATE HYDROCHLORIDE 60,0 mg

60 mg54043554/1.2/0435RegisteredS6None

Regulatory status

Where S6 sits on the scale

Prescription-only, no repeats without a new prescription.

Schedule 6 covers the most tightly controlled ordinary prescription medicines. Every dispensing needs its own new prescription; nothing can be repeated on the same script. When prescribed, the quantity must be written out in both figures and words. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S6, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.

Consolidated Schedules listings for Methylphenidate hydrochloride

  • S6: Methylphenidate

    • and its derivatives, unless listed in another Schedule.

    Consolidated Schedules 06 July 2026, line 10310

Pharmacological class: Psychoanaleptics (antidepressants). (class 1.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C14H19NO2233.31 g/mol

Methyl 2-phenyl-2-piperidin-2-ylacetate

Drag to rotate. Structure from PubChem CID 4158.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles